Safety test of the intravenous use of allogeneic mesenchymal stem cells in
domestic cats
cats
steam cells
safety
Over the years, felines have gained increasing acceptance as pets, which is reflected in the growth
of the population of these pets (RECHE JUNIOR 2018). The use of stem cells, also called cell therapy, has great potential for
applicability to feline diseases, but there are still several questions to be answered regarding its use, including its
safety(QUIMBY 2018). Thus, the present study aimed to evaluate the safety of using halogenated mesenchymal
stem cells(MSCs) intravenously by monitoring physical parameters (mucosal staining, lymph node examination,
heart and respiratory rate, rectal temperature). and hematology of a group of 8 healthy cats. Applications were
carried out atthe Clinic School of Veterinary Medicine of FACISA to monitor possible adverse reactions. Among the
physical parameters evaluated previously and throughout the study, no relevant changes were observed. As for the
hematological parameters, the results indicate that in the first week, the only parameter whose average showed a
significant reduction was Alkaline Phosphatase. Two weeks after the application of CTM, three parameters showed a
significant reduction in the average in relation to the levels observed before the beginning of the experiment, which
are Hematocrit, Hemoglobin and Creatinine. After 3 weeks of MSC application, all parameters returned to levels
close to the original values. The present study points to the safety of using allogeneic MSCs intravenously in cats at
the established dose.